BC Cancer - Vancouver

600 W 10th Avenue
Vancouver, BC V5Z 4E6

Clinical Trial Unit Manager
Darko Curman
604-877-6000 x673226
dcurman@bccancer.bc.ca

Pancreas

An Open-label, Multi-center, Phase 1b Study to Investigate the Safety and Tolerability of SLC-0111 (WBI-5111) in Combination With Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Subjects Positive for Carbonic Anhydrase IX (CAIX)

Cancer Type
Pancreas
Phase I
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

NETTER-2: A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

Cancer Type
Pancreas
Phase III
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

PASS-01: Pancreatic Adenocarcinoma Signature Stratification for Treatment

GATA6: Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma: A Multicentre Canadian Phase II Study

Cancer Type
Pancreas
Phase II
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date
Back to top